Zhiming Zhang

Zhiming Zhang

Auto-generated profile, based on publicly available information

Zhiming Zhang

Department of Orthopedics The Second Xiangya Hospital of Central South University Changsha Hunan China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
ZZZhiming Zhang
Zhiming Zhang
BLBinfeng Liu
Binfeng Liu
ZLZhengjun Lin
Zhengjun Lin
LMLin Mei
Lin Mei
RCRuiqi Chen
Ruiqi Chen
ZLZhihong Li
Zhihong Li
Secreted phosphoprotein 1 (SPP1), also known as osteopontin, is a phosphorylated protein. High SPP1 expression levels have been detected in multiple cancers and are associated with poor prognosis and reduced survival rates. However, only a few pan‐cancer analyses have targeted SPP1. We conducted a comprehensive analysis using multiple public databases, including TIMER and TCGA, to investigate the expression levels of SPP1 in 33 different tumor types. In addition, we verified the effect of SPP1 on osteosarcoma. To assess the impact of SPP1 on patient outcomes, we employed univariate Cox regression and Kaplan–Meier survival analyses to analyze overall survival (OS), disease‐specific survival (DSS), and progression‐free interval (PFI) in these tumor patients. We also explored SPP1 gene alterations in various tumor tissues using cBioPortal. We then examined the relationship between SPP1 and clinical characteristics, TME, immune regulatory genes, immune checkpoints, TMB, and MSI using R language. In addition, we used GSEA to investigate the molecular mechanisms underlying the role of SPP1. Bioinformatics analysis indicated that SPP1 was upregulated in 17 tumors. Overexpression of SPP1 results in poor OS, DSS, and PFI in CESC, ESCA, GBM, LGG, LIHC, PAAD, PRAD, and skin cutaneous melanoma. SPP1 expression was positively associated with immunocyte infiltration, immune regulatory genes, immune checkpoints, TMB, MSI, and drug sensitivity in certain cancers. We found that high expression of SPP1 in osteosarcoma was related to drug resistance and metastasis and further demonstrated that SPP1 can stimulate osteosarcoma cell proliferation via CCND1 by activating the PI3K/Akt pathway. These findings strongly suggest that SPP1 is a potential prognostic marker and novel target for cancer immunotherapy.

21 June 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YWYihan Wang
Yihan Wang
CXChangnan Xie
Changnan Xie
ZZZhiming Zhang
Zhiming Zhang
HLHaining Liu
Haining Liu
HXHaixia Xu
Haixia Xu
LZLixin Zhu
Lixin Zhu

1 December 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ZZZhiming Zhang
Zhiming Zhang
GWGuofeng Wu
Guofeng Wu
YCYanlin Cao
Yanlin Cao
CLChun Liu
Chun Liu
YJYanglei Jin
Yanglei Jin
LZLixin Zhu
Lixin Zhu

14 October 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
ZZZhiming Zhang
Zhiming Zhang
BLBinfeng Liu
Binfeng Liu
LMLin Mei
Lin Mei
RCRuiqi Chen
Ruiqi Chen
HZHaoyang Zhou
Haoyang Zhou
ZLZhihong Li
Zhihong Li